Canada’s national pharmacare program is currently at a standstill, as the federal Health Minister has confirmed that there are no ongoing discussions with the remaining provinces and territories to finalize agreements. The recent budget did not allocate additional funds to expand nationwide coverage, raising concerns about the future of the public drug plan.
Over a year ago, the Trudeau government passed the Canada Pharmacare Act, pledging to negotiate agreements with all provinces and territories to cover the costs of contraceptive and diabetes medications and devices. While four regions – B.C., Manitoba, P.E.I., and Yukon – signed deals with Ottawa before the last federal election, no new agreements have been announced since then.
Health Minister Marjorie Michel stated that the department is not actively engaged in talks to secure additional agreements at the moment. Despite ongoing conversations with provinces and territories about next steps, no new deals have been finalized.
Some provinces are willing to sign agreements under the original framework, while others have expressed concerns about the program’s long-term sustainability. Alberta, for instance, has raised issues about the scope of coverage and financial sustainability, emphasizing the need for clarity on the government’s vision for pharmacare.
The lack of clarity and absence of new funding in the recent budget have raised questions about the government’s commitment to advancing pharmacare. Advocates point out that only a small percentage of Canadians are currently covered under the existing agreements, highlighting the urgent need for nationwide drug insurance to ensure equitable access to essential medications.
The federal government’s messaging on pharmacare has been inconsistent, with Prime Minister Mark Carney previously committing to signing remaining agreements but not providing adequate funding to support new deals. This has led to criticism from advocacy groups and opposition parties, who argue that the government is delaying crucial decisions on expanding pharmacare access across the country.